Northern, WI  12/12/12 (BasicsMedia)  — Wow it’s 12/12/12 !!!!  I have not been this excited since 11/11/11 !!  But let us look at movers from yesterday so we can watch them bounce, continue their move or retrace.  Here are 4 stocks up yesterday which had volume and large % moves and 1 down.  Happy trading!! Thank You as always for reading…we will have a Mobile App available soon!!

BG Medicine: +138% - (NASDAQ:BGMD) exploded higher yesterday vaulting this small company headlong into the media cycle and away from Fiscal Cliff talk at least for a minute.  There has been a ton of hope for BG Medicine (NASDAQ:BGMD) in 2012 as shares started out the year at $5 p/s traded up to a hopeful $8 before sliding most of the year to recent lows near $1.  Todays action gets it halfway back and recoups some of the sell off for shareholders.  The stock was 118% higher.

BG Medicine, Inc. (BGMD), a MicroCap stock worth a paltry $50M in value is focused on the development and commercialization of novel cardiovascular tests, today announced that it has obtained a CE Mark enabling the commercial sale of the CardioSCORE(TM) test in the EU and other countries that recognize the CE Mark. The CardioSCORE test is the company’s patented diagnostic blood test designed to dramatically improve risk prediction of major cardiovascular events beyond traditional risk factor assessments, such as the Framingham Risk Score and European SCORE.

Somaxon Pharma (NASDAQ:SOMX): +70%   Under the terms of the agreement, which has been unanimously approved by the boards of directors of both companies, Somaxon stockholders will receive aggregate consideration equal to $25 mln in Pernix common stock. The number of shares of Pernix common stock to be issued to the stockholders of Somaxon will be based on the volume-weighted average price of Pernix’s common stock over the 30 day period ending on the day immediately prior to the closing of the proposed merger, subject to limitations on the maximum and minimum number of shares of Pernix common stock issuable in the transaction based on a price range of $6.00 to $9.00 per share.

Acura Pharma (NASDA:ACUR): +56% -  I have never understood Meth..but I do know it ruins lives very quickly, so I did a bit of research on any company in the fight to reduce the carnage it is causing in our culture.  What I found is that the active ingredient in Meth is pseudoephedrine - and when extracted and eventually becomes this dangerous drug killing our children.  I am not a scientist, but any company who spends R&D money to detour the Meth Labs around the U.S.  is good in my book.

Acura (NASDAQ:ACUR) is trading 56% higher today after releasing press on this product which will curb and abate the production of this terrible drug , the company said , ” The launch of Nexafed® is a significant milestone for Acura and in the continued fight against meth in the U.S.,” said Robert B. Jones, president and chief executive officer of Acura Pharmaceuticals. “Acura is highly committed to addressing the needs of local communities by investing in the development of abuse-deterrent technologies and medicines. It’s not about innovating once, but continuing to improve on the technology without compromising efficacy.”

TNS (NYSE:TNS) – TNS Inc, a maker of networking products, agreed to be acquired by an investor group led by Siris Capital Group in a deal valued at about $862 million.Siris, a private-equity firm, will pay $21 a share in cash, a 47 percent premium over the stock’s average price over the past month, according to a statement today. The companies expect the deal to close in the first quarter.

TNS, founded in 1990, supplies networking products and services to retailers, banks and telecommunications providers. Amid slowing sales, the company is changing its focus from selling older, so-called legacy networks to newer data- communication applications. TNS said it will maintain this shift as a closely held affiliate of Siris.

Reeds Beverage (NASDAQ:REED)  –  Reed shares had some low volume selling, it could also be some profit taking.  This has been a great stock in 2012 starting out theyear at $1.11 and trading up to $8 p/s , the CEO is a smart guy and the beverages are great!!  I am happy for Chris Reed he has worked hard here!!

 

Disclaimer:  We have no position in any stock mentioned here.

 

DISCLAIMER: This content is neither an offer nor recommendation to buy or sell any security. We hold no investment licenses and are thus neither licensed nor qualified to provide investment advice. The content in this report or email is not provided to any individual with a view toward their individual circumstances. While all information is believed to be reliable, it is not guaranteed by us to be accurate. Individuals should assume that all information contained in our newsletter is not trustworthy unless verified by their own independent research. Also, because events and circumstances frequently do not occur as expected, there will likely be differences between the any predictions and actual results. Always consult a real licensed investment professional before making any investment decision. Be extremely careful, investing in securities carries a high degree of risk; you may likely lose some or all of the investment.